FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W43150112> ?p ?o ?g. }

• W43150112 endingPage "8" @default.
• W43150112 startingPage "3684" @default.
• W43150112 abstract "Few studies have given suggestions on appropriate initiation insulin dosage when combined with oral antidiabetic drugs (OADs). This research was to investigate appropriate initiation insulin doses for insulin-naive type 2 diabetes patients with different combinations and the relationship between insulin dosage and relevant factors.This was a randomized, open-label, treat to target study. The target was 20% decrease of both fasting plasma glucose (FPG) and 2 hours post-breakfast blood glucose (P2hBG). One hundred and forty-seven insulin-naive Chinese patients recruited were randomly assigned to 3 groups: group A, patients received insulin monotherapy; group B, received insulin plus metformin (0.5 g, tid) and group C, received insulin plus metformin (0.5 g, tid) and pioglitazone (15 mg, qd). Insulin doses were initiated with a dose of 0.3 U×kg(-1)×d(-1) and titrated according to FPG and P2hBG till reached the targets.Both the time of getting 20% reduction of FPG and P2hBG showed significant differences among the three groups. The time was shortest in Group C. The insulin doses needed to achieve glucose reduction of 20% in three treatment groups were (0.40 ± 0.04) U×kg(-1)×d(-1) for Group A, (0.37 ± 0.04) U×kg(-1)×d(-1) for Group B, and (0.35 ± 0.03) U×kg(-1)×d(-1) for Group C, respectively. Multiple linear stepwise regression analysis showed that insulin doses correlated with body weight, FPG, diabetes duration, age and history of sulfonylurea treatment. The standardized regression coefficients were 0.871, 0.322, 0.089, 0.067 and 0.063 (with all P < 0.05).To achieve blood glucose's reduction of 20% within safety context, initial insulin doses were recommended as the following: 0.40 U×kg(-1)×d(-1) for insulin mono-therapy, 0.37 U×kg(-1)×d(-1) for insulin plus metformin treatment, and 0.35 U×kg(-1)×d(-1) for insulin plus metformin and pioglitazone treatment in Chinese type 2 diabetes outpatients. Body weight is found the most closely related factor to the insulin dosage." @default.
• W43150112 created "2016-06-24" @default.
• W43150112 creator A5003690296 @default.
• W43150112 creator A5031646804 @default.
• W43150112 creator A5031873259 @default.
• W43150112 creator A5035779976 @default.
• W43150112 creator A5043874453 @default.
• W43150112 creator A5066107847 @default.
• W43150112 date "2010-12-01" @default.
• W43150112 modified "2023-10-18" @default.
• W43150112 title "Appropriate insulin initiation dosage for insulin-naive type 2 diabetes outpatients receiving insulin monotherapy or in combination with metformin and/or pioglitazone." @default.
• W43150112 cites W2133206706 @default.
• W43150112 cites W2146901298 @default.
• W43150112 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22166651" @default.
• W43150112 hasPublicationYear "2010" @default.
• W43150112 type Work @default.
• W43150112 sameAs 43150112 @default.
• W43150112 citedByCount "1" @default.
• W43150112 countsByYear W431501122014 @default.
• W43150112 crossrefType "journal-article" @default.
• W43150112 hasAuthorship W43150112A5003690296 @default.
• W43150112 hasAuthorship W43150112A5031646804 @default.
• W43150112 hasAuthorship W43150112A5031873259 @default.
• W43150112 hasAuthorship W43150112A5035779976 @default.
• W43150112 hasAuthorship W43150112A5043874453 @default.
• W43150112 hasAuthorship W43150112A5066107847 @default.
• W43150112 hasConcept C126322002 @default.
• W43150112 hasConcept C134018914 @default.
• W43150112 hasConcept C2777180221 @default.
• W43150112 hasConcept C2778384471 @default.
• W43150112 hasConcept C2778854520 @default.
• W43150112 hasConcept C2779306644 @default.
• W43150112 hasConcept C2780323712 @default.
• W43150112 hasConcept C555293320 @default.
• W43150112 hasConcept C71924100 @default.
• W43150112 hasConceptScore W43150112C126322002 @default.
• W43150112 hasConceptScore W43150112C134018914 @default.
• W43150112 hasConceptScore W43150112C2777180221 @default.
• W43150112 hasConceptScore W43150112C2778384471 @default.
• W43150112 hasConceptScore W43150112C2778854520 @default.
• W43150112 hasConceptScore W43150112C2779306644 @default.
• W43150112 hasConceptScore W43150112C2780323712 @default.
• W43150112 hasConceptScore W43150112C555293320 @default.
• W43150112 hasConceptScore W43150112C71924100 @default.
• W43150112 hasIssue "24" @default.
• W43150112 hasLocation W431501121 @default.
• W43150112 hasOpenAccess W43150112 @default.
• W43150112 hasPrimaryLocation W431501121 @default.
• W43150112 hasRelatedWork W1995813412 @default.
• W43150112 hasRelatedWork W1997867512 @default.
• W43150112 hasRelatedWork W2020932776 @default.
• W43150112 hasRelatedWork W2061988825 @default.
• W43150112 hasRelatedWork W2072752555 @default.
• W43150112 hasRelatedWork W2156803989 @default.
• W43150112 hasRelatedWork W2184305164 @default.
• W43150112 hasRelatedWork W2904158334 @default.
• W43150112 hasRelatedWork W2905642444 @default.
• W43150112 hasRelatedWork W4214898905 @default.
• W43150112 hasVolume "123" @default.
• W43150112 isParatext "false" @default.
• W43150112 isRetracted "false" @default.
• W43150112 magId "43150112" @default.
• W43150112 workType "article" @default.